Epibatidine: A nicotinic acetylcholine receptor agonist releases monoaminergic neurotransmitters: In vitro and in vivo evidence in rats

Journal of Pharmacology and Experimental Therapeutics

Volumn 276, Issue 2, 1996, Pages 509-515

  Sacaan, Aida I ^a,b   Menzaghi, Frederique ^a   Dunlop, John L ^a   Correa, Lucia D ^a   Whelan, Kevin T ^a   Lloyd, G Kenneth ^a  

^a SIBIA Corp   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE; EPIBATIDINE; FUSED HETEROCYCLIC RINGS; NICOTINIC AGENT; NORADRENALIN; PYRIDINE DERIVATIVE; TETRODOTOXIN;

ANIMAL; ARTICLE; DOSE RESPONSE; DRUG EFFECT; IN VITRO STUDY; MALE; MOTOR ACTIVITY; RAT; SECRETION; SPRAGUE DAWLEY RAT; STEREOISOMERISM;

ANIMALS; BICYCLO COMPOUNDS, HETEROCYCLIC; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; MOTOR ACTIVITY; NICOTINIC AGONISTS; NOREPINEPHRINE; PYRIDINES; RATS; RATS, SPRAGUE-DAWLEY; STEREOISOMERISM; TETRODOTOXIN;

EID: 0030088073     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. AEQUEROS, L , NAQUIRA, D. AND ZUNINO, E. Nicotine-induced release of catecholamines from rat hippocampus and striatum. Biochem. Pharmacol. 27: 2667-2674, 1978.
2. BADIO, B. AND DALY, J. W.: Epibatidine, a potent analgetic and nieotinic agonist. Mol. Pharmacol. 45: 563-569, 1994.
3. BENWELL, M. E. M. AND BALFOUR, D. J. K.: The effects of acute and repeated nicotine treatment on nucleus accumbens dopamine and locomotor activity. Br. J. Pharmacol. 105: 849-856, 1992.
4. CLARKE, P. B. S. AND KUMAR, R.: Effects of nicotine on locomotor activity in non-tolerant and tolerant rats. Br. J. Pharmacol. 78: 329-337, 1983a.
5. CLARKE, P. B. S. AND KUMAR, R.: Characterisation of the locomotor stimulant action of nicotine in tolerant rats. Br. J. Pharmacol. 80: 587-594, 1983b.
6. CLARKE, P. B. S AND PERT, A.: Autoradiographic evidence for nicotine receptors on nigrostriatal and mesolimbic dopaminergic neurons. Brain Res. 348: 355-358, 1985.
7. DAMAJ, M. I. AND MARTIN, B. R.: Is the dopaminergic system involved in the central effects of nicotine in mice? Psychopharmacology 111: 106-108, 1993.
8. DAMSMA, G., WESTERNIK, B. H. C., DE VRIES, J. B. AND HORN, A. S.: The effect of systemically applied cholinergic drugs on the striatal release of dopamine and its metabolites, as determined by automated brain dialysis in conscious rats. Neurosci. Lett. 89: 349-354, 1988.
9. DE BELLEROCHE, J. D. AND BRADFORD, H. F.: Biochemical evidence for the presence of presynaptic receptors on dopaminergic nerve terminals. Brain Res. 142: 53-68, 1978.
10. EL-BIZRI, H. AND CLARKE, P. B. S.: Blockade of nicotinic receptor-mediated release of dopamine from striatal synaptosomes by chlorisondamine and other nicotinic antagonists administered in vitro. Br. J Pharmacol. 111: 406-413, 1994.
11. 3H]-SCH-23390 to dopaminergic receptor sites in rat striatal tissue. Biochem Pharmacol. 38: 473-480, 1989.
12. IMPERATO, A., MULAS, A. AND DI CHIARA, G.: Nicotine preferentially stimulates dopamine release in the limbic system of freely moving rats. Eur. J. Pharmacol. 132: 337-339, 1986.
13. IWAMOTO, E. T.: An assessment of spontaneous activity of rats administered morphine, pheneyclidine, or nicotine using automated and observational methods. Psychopharmacology 84: 374-382, 1984.
14. 3H]-eticlopride in the rat brain: Evidence for selective labeling of dopamine receptors Eur. J. Pharmacol. 120: 217-226, 1986.
15. LEIKOLA-PELHO, T. AND JACKSON, D. M.: Preferential stimulation of locomotor activity by ventral tegmental microinjections of (-)-nicotine. Pharmacol. & Toxicol. 70: 50-52, 1992.
16. LUETJE, C. W. AND PATRICK, J.: Both α-and β-subunits contribute to the agonist sensitivity of neuronal nicotinic acetylcholine receptors. J. Neurosci. 11: 837-845, 1991.
17. MARSHALL, D. L., REDFERN, P. H. AND WONNACOTT, S.: Release of dopamine from the striatum by nicotine is TTX-sensitive: In vivo evidence of "preterminal" nAChRs. Br. J. Pharmacol. 114: 340P, 1995.
18. MUSEO, E. AND WISE, R. A.: Microinjections of a nicotinic agonist into dopamine terminal fields: Effects on locomotion Pharmacol. Biochem. Behav. 37: 113-116, 1990.
19. 2 dopamine receptors in mediating nicotine-induced hyperactivity in rats. Psychopharmacology 104: 343-350, 1991.
20. PERRINS, R. AND ROBERTS, A.: Nicotinic and muscarinic Ach receptors in rhythmically active spinal neurones in the Xenopus laevis embryo. J. Physiol. (Lond.) 478: 221-228, 1994.
21. QIAN, C., LI, T., SHEN, T. Y., LIBERTINE-GARAHAN, L., ECKMAN, J., BIFTU, T. AND IP, S.: Epibatidine is a nicotinic analgesic. Eur. J. Pharmacol. 250: R13-R14, 1993.
22. REAVILL, C. AND STOLERMAN, I. P.: Locomotor activity in rats after administration of nicotinic agonists intracerebrally. Br. J. Pharmacol. 99: 273-278, 1990.
23. ROBBINS, T. W.: A critique of methods available for the measurement of spontaneous motor activity. In Handbook of Psychopharmacology, ed. by L. L. Iversen., S. D. Iversen., and S. H. Snyder, vol. 7, pp. 37-82, Plenum Press, New York, 1977.
24. SACAAN, A. I., DUNLOP, J. L AND LLOYD, G. K.: Pharmacological characterization of neuronal acetylcholine gated ion channel receptor-mediated hippocampal norepinephrine and striatal dopamine release from rat brain slices. J. Pharmacol. Exp. Ther. 274: 224-230, 1995.
25. SARGENT, P. B.: The diversity of neuronal nicotinic acetylcholine receptors. Annu. Rev. Neurosci. 16: 403-443, 1993.
26. SCHAEFFER, G. J. AND MICHAEL, R. P.: Task specific effects of nicotine in rats. Neuropharmacology 25: 125-131, 1986.
27. SPANDE, T. F., GARRAFFO, H. M., EDWARDS, M. W., YEH, H. J. C., PANNEL, L. L. AND DALY, J. W.: Epibatidine: A novel (chloropyridyl)azabicycloheptane with potent analgesic activity from an Ecuadoran poison frog. J. Am. Chem. Soc. 114: 3475, 1992.
28. SULLIVAN, J. P., DECKER, M. W., BRIONI, J. D., DONNELLY-ROBERTS, D., ANDERSON, D. J., BANNON, A. W., KANG, C., ADAMS, P., PIATTONI-KAPLAN, M , BUCKLEY, M. J., GOPALAKRISHNAN, M., WILLIAMS, M. AND ARNERIC, S. P.: (±)-Epibatidine elicits a diversity of in vitro and in vivo effects mediated by nicotinic acetylcholine receptors. J. Pharmacol. Exp. Ther. 271: 624-631, 1994.
29. UNGERSTEDT, U. AND ARBUTHNOTT, G.: Quantitative recording of rotational behaviour in rats after 6-hydroxy-dopamine lesions of the nigro-striatal dopamine system. Brain Res. 24: 485-493, 1970.
30. VIDAL, C. AND CHANGEUX, J.-P.: Nicotinic and muscarinic modulations of excitatory synaptic transmission in the prefrontal cortex in vitro. Neuroscience 56: 23-32, 1993.
31. 3H]-dopamine from rat brain slices. Neuropharmacology 13: 693-700, 1974
32. WONG, L. A. AND GALLAGHER, J. P.: Pharmacology of nicotinic receptor-mediated inhibition in rat dorsolateral septal neurons. J. Physiol. (Lond.) 436: 325-346, 1991.